Fuller & Thaler Asset Management, Inc. Emergent Bio Solutions Inc. Transaction History
Fuller & Thaler Asset Management, Inc.
- $25.4 Billion
- Q1 2025
A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 147,480 shares of EBS stock, worth $958,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147,480
Previous 156,065
5.5%
Holding current value
$958,620
Previous $1.49 Million
51.98%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding EBS
# of Institutions
177Shares Held
38.3MCall Options Held
94.1KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$20.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$16.3 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$14.9 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$11.1 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $324M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...